Neuromodulation to Facilitate the Effect of Ketamine
Completed
- Conditions
- DepressionChronic PainSubstance Abuse
- Interventions
- Other: co-administration of TMS and infused ketamine
- Registration Number
- NCT01816958
- Lead Sponsor
- The Neuroscience Center, LLC
- Brief Summary
application of external neuromodulation along with ketamine infusion.
- Detailed Description
apply TMS concurrent with ketamine infusion in order to increase the likliehood \& strength of therapeutic benefit
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
- chronically ill,
- treatment-resistant
Exclusion Criteria
- active psychosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description chronic depression and/or pain co-administration of TMS and infused ketamine co-administration of TMS and infused ketamine for patients with chronic pain of psyche and/or soma
- Primary Outcome Measures
Name Time Method Global Assessment of Function in DSM-4R up to 3 years treat in order to cause remission of disability
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Neuroscience Center
🇺🇸Deerfield, Illinois, United States